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ABSTRACT
This study describes the characterisation by
pulsed-ﬁeld gel electrophoresis (PFGE), multi-
locus variable number tandem repeat analysis
(MLVA) typing and antimicrobial resistance
proﬁles of 35 Salmonella enterica serovar Typhimu-
rium isolates, mostly from infections in children
who acquired an infection outside hospitals in the
Gomel region of Belarus. Thirty-one isolates were
highly similar according to PFGE and MLVA
typing, were multidrug-resistant, including resis-
tance to ceftiofur, and harboured the blaCTX-M-5
gene. These results indicate that a common source
may have been responsible for most of the
infections.
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Salmonella is one of the most common causes of
human bacterial gastroenteritis worldwide, with
Salmonella enterica serovar Typhimurium and
S. enterica serovar Enteritidis being the serovars
involved most frequently [1,2]. In recent years, an
increase in the occurrence of antimicrobial-resis-
tant Salmonella isolates has been observed in
several countries [3–5]. Not all resistance to
antimicrobial agents is of equal importance.
Fluoroquinolones are the drug of choice in many
countries for the treatment of salmonellosis in
humans, and resistance to this class of antimicro-
bial agent is associated with increased morbidity
and mortality [6,7]. Cephalosporins are the drugs
of choice for the treatment of salmonellosis in
children, to whom ﬂuoroquinolones must not be
administered because of the risk of toxicity.
Multidrug-resistant Salmonella Typhimurium
isolates have recently emerged as an important
cause of nosocomial infections in children in
Belarus and Russia [8]. Molecular characterisation
of 34 isolates from nosocomial infections revealed
that the isolates probably belonged to the same
clone, and that all contained the blaCTX-M-5 gene
[8]. The purpose of the present study was
to characterise isolates obtained primarily from
children who had acquired an infection outside
hospitals in order to determine whether these
isolates might also have a common origin.
In total, 35 isolates were selected from among
457 S. Typhimurium isolates collected at Gomel
State Medical University, Belarus, and shipped
subsequently to the National Food Institute,
Copenhagen, Denmark. Multidrug-resistant iso-
lates were frequently detected in the diagnostic
laboratory, and most of the isolates in the present
study were selected from among these. Three
fully-susceptible isolates were also included. The
isolates were chosen randomly to represent iso-
lates from Gomel city and the surrounding dis-
tricts. Four isolates were from patients who
developed infection during hospitalisation, and
one isolate was from a patient who had been
hospitalised previously. The remaining 30 isolates
were from patients with no previous record of
hospitalisation. Three isolates from Rechitsa dis-
trict were from members of the same family, as
was the case for two isolates from Gomel city. All
other isolates were from different families with no
known contacts. All isolates were identiﬁed as
S. enterica, were serotyped and phage-typed, and
their MICs of antimicrobial agents were deter-
mined in microtitre plates according to CLSI
guidelines, as described previously [9–11]. The
following antimicrobial agents were tested:
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ampicillin, amoxycillin–clavulanic acid, apramy-
cin, ceftiofur, chloramphenicol, ciproﬂoxacin,
ﬂorfenicol, gentamicin, nalidixic acid, neomycin,
spectinomycin, streptomycin, sulphamethoxazole,
tetracycline and trimethoprim. The isolates were
further characterised using pulsed-ﬁeld gel
electrophoresis (PFGE) and multilocus variable
number tandem repeat analysis (MLVA) as
described previously [12,13]. Comparison of the
PFGE and MLVA proﬁles was undertaken with
Bionumerics v.2.5 (Applied Maths, Sint-Martens-
Latem, Belgium), using a weighted comparison
with the following weights: PFGE, 3; MLVA, 2;
and antibiogram, 1. The similarity coefﬁcient was
based on an experimental average and the use of
UPGMA. The tolerance percentage for the PFGE
patterns was 3.8%. The presence of the blaTEM,
blaCTX, blaCMY-1, blaCMY-2, blaSHV and blaACC genes
was investigated by PCR as described previously
[14].
All 35 isolates were conﬁrmed as S. Typhimu-
rium, but were non-typeable with phages. Thirty-
one of the isolates were multidrug-resistant,
with the most common pattern comprising
resistance to amoxycillin–clavulanic acid, ampi-
cillin, ceftiofur, chloramphenicol, gentamicin,
neomycin, spectinomycin, streptomycin, sulph-
onamides, tetracycline and trimethoprim. Five of
the 31 isolates were also resistant to quinolones.
All 31 isolates harboured the blaCTX-M-5 gene.
Six different PFGE types were found among
the 35 isolates (Fig. 1). Four of these types,
representing the 31 multidrug-resistant isolates
and a single isolate resistant to only three antibi-
otics, showed high similarity (one to three bands
difference from the most common type). MLVA
typing revealed seven different types, and was, in
some cases, able to subdivide the PFGE types.
However, the opposite was also the case. Com-
bined use of MLVA, PFGE and antimicrobial
resistance proﬁling divided the isolates into 17
different types, with some minor clusters. Thus,
isolates 857, 858 and 860 were from patients from
the same family and were distinguishable from
the remaining isolates.
Molecular and phenotypic characterisation
revealed that the multidrug-resistant isolates were
probably clonally related. Although 15 different
types were found among the 31 cephalosporin-
resistant isolates, the proﬁles had so many char-
acteristics in common that a common origin
seems likely [15,16]. However, this variation also
Fig. 1. Cluster analysis of 35 Salmonella enterica serovar Typhimurium isolates from Gomel region, Belarus, based on a
combination of results from pulsed-ﬁeld gel electrophoresis (PFGE), multilocus variable number tandem repeat analysis
(MLVA) and antibiogram typing. ABRES, antimicrobial resistance; AUG, amoxycillin–clavulanic acid; AMP, ampicillin;
APR, apramycin; XNL, ceftiofur; CHL, chloramphenicol; CIP, ciproﬂoxacin; FFN, ﬂorfenicol; GEN, gentamicin; NAL,
nalidixic acid; NEO, neomycin; SPE, spectinomycin; STR, streptomycin; SMX, sulphamethoxazole; TET, tetracycline; TMP,
trimethoprim.
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indicates that the clone has spread for some time
in order to evolve these differences.
Outbreaks with S. enterica are associated most
commonly with consumption of contaminated
food products of animal origin. A previous report
described nosocomial outbreaks involving a
single clone of cephalosporin-resistant S. enterica
Typhimurium containing the blaCTX-M-5 gene in
Belarus, although the source of these isolates was
not identiﬁed [8]. In the present study, blaCTX-M-5
was found to be associated with cephalosporin
resistance. In contrast to the study conducted by
Edelstein et al. [8], the isolates characterised in the
present study were mainly from non-hospitalised
patients, indicating a community reservoir for this
extended-spectrum b-lactamase producer. The
isolates from the previous study were not avail-
able for comparison, and the PFGE proﬁles were
performed using different methodologies, but a
visual comparison of the proﬁles indicates that
the isolates from the two studies were closely
related.
Enterobacteriaceae producing CTX-M enzymes
are emerging worldwide, with the CTX-M-5
variant having been reported mainly in eastern
Europe and Russia [8,17,18], indicating the regio-
nal spread of this gene. MLVA typing is a new
and sensitive typing technique that has, to date,
been used only in a limited number of studies.
The present study demonstrated that MLVA
can further subdivide PFGE types, as reported
previously [19], although PFGE typing can also
subdivide MLVA types. MLVA typing may be
too sensitive to determine clonality among iso-
lates that have spread over a prolonged period.
Thus, typing techniques must be chosen according
to the purpose of the investigation, and should
always be used in combination and be supported
by epidemiological data [15,16]. The present
study indicated that multidrug-resistant S. enterica
Typhimurium isolates infecting children in the
Gomel region of Belarus belong to the same or a
closely related clone, which suggests a common
source of the infections caused by these organisms.
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ABSTRACT
Bone infection and metastatic spread in cases of
Buruli ulcer imply that Mycobacterium ulcerans is
able to survive and multiply at 37C. This study
investigated the survival at 37C of M. ulcerans
isolates from diverse geographical and clinical
sources. Although the viability of all isolates
decreased after a few days at 37C, viable
bacilli remained after 13 days at 37C in most
instances. African isolates of M. ulcerans were
more thermotolerant than isolates from temperate
regions. Isolates from skin and bone lesions of
the same patients showed no difference in
thermotolerance.
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Mycobacterium ulcerans, the causative agent of
Buruli ulcer (BU), grows optimally on mycobac-
teriological media at 30–32C [1]. M. ulcerans
classically infects skin and subcutaneous tissue,
where the pathogen encounters favourable
growth temperatures. However, metastatic
spread to distant skin sites or bone also occurs
[2–5], suggesting that M. ulcerans is able to sur-
vive and ⁄ or multiply at 37C. The present study
investigated the survival of M. ulcerans at 37C on
Lo¨wenstein–Jensen medium. The results may
have implications for: (i) a better understanding
of the clinical features of the disease, with bone
involvement resulting from metastatic spread;
(ii) the treatment of lesions with local heat; and
(iii) the epidemiology and transmission of the
disease in relation to survival of M. ulcerans in the
environment at high temperatures.
Seventeen isolates ofM. ulcerans from ten coun-
tries were initially studied. Tubes of Lo¨wenstein–
Jensen medium were inoculated with serial
dilutions of suspensions of bacteria and incubated
at 37C for 0, 3, 6, 9 or 24 h, and 2, 3, 6, 9 or 13 days,
and thereafter at 32C for 12 weeks. The number of
surviving bacilli was estimated by counting the
number of CFU. Inactivation curves were obtained
for each isolate by plotting CFU ⁄mL against
exposure time at 37C on a semi-logarithmic scale.
The slope of the inactivation curves was expressed
as decimal reduction time (D), measuring heat
resistance and the time needed to inactivate 90%
of the bacterial population at a given temperature.
A higher D value thus indicates a greater thermo-
tolerance [6,7].
Table 1 shows that a decrease in viability
occurred for all isolates after a few days at 37C,
but with large variations for individual isolates.
However, for all isolates except those from Japan,
China and French Guiana, viable bacilli were still
present after incubation for 13 days at 37C. The
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